What was the market valuation of the US medical foods market in 2024?

The market valuation of the US medical foods market was $5.5 Billion in 2024. Read More

What is the projected market valuation for the US medical foods market by 2035?

The projected market valuation for the US medical foods market is $9.2 Billion by 2035. Read More

What is the expected CAGR for the US medical foods market during the forecast period 2025 - 2035?

The expected CAGR for the US medical foods market during the forecast period 2025 - 2035 is 4.79%. Read More

Which companies are considered key players in the US medical foods market?

Key players in the US medical foods market include Nestle, Danone, Abbott Laboratories, Mead Johnson Nutrition, Baxter International, Fresenius Kabi, Hormel Foods, Reckitt Benckiser, and Perrigo. Read More

What are the main segments of the US medical foods market?

The main segments of the US medical foods market include Nutritional Ingredients, Route of Administration, Form, Application, and Distribution Channel. Read More

What was the valuation of the Nutritional Ingredients segment in 2024?

The valuation of the Nutritional Ingredients segment was $5.5 Billion in 2024, with Vitamins and Minerals at $1.1 Billion. Read More

How does the Oral route of administration compare to Enteral in terms of market valuation?

In 2024, the Oral route of administration was valued at $2.75 Billion, while the Enteral route was also valued at $2.75 Billion. Read More

What is the projected valuation for the Pills form segment by 2035?

The projected valuation for the Pills form segment is $3.5 Billion by 2035. Read More

Which application segment is expected to grow the most by 2035?

The Nutritional Deficiency application segment is expected to grow the most, with a projected valuation of $1.8 Billion by 2035. Read More

What distribution channel is anticipated to have the highest valuation by 2035?

The Retail Pharmacies distribution channel is anticipated to have the highest valuation, projected at $3.2 Billion by 2035. Read More

US Medical Foods Market

ID: MRFR/MED/12139-CR

100 Pages

Satyendra Maurya

Last Updated: April 02, 2026

United States Medical Foods Market Report 2025–2035: Industry Size, Share, and Growth Forecasts Across Key Segments—Diabetes, Oncology, Neurological Disorders, and Inborn Errors of Metabolism (PKU)

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Nutritional Ingredients (USD Billion)
  1. 4.1.1 Vitamins and Minerals
  2. 4.1.2 Proteins
  3. 4.1.3 Omega-3
  4. 4.1.4 Isoflavones
  5. 4.1.5 Phytosterols
  6. 4.1.6 Others
2. 4.2 Chemicals and Materials, BY Route of Administration (USD Billion)
  1. 4.2.1 Oral
  2. 4.2.2 Enteral
3. 4.3 Chemicals and Materials, BY Form (USD Billion)
  1. 4.3.1 Pills
  2. 4.3.2 Powder
  3. 4.3.3 Others
4. 4.4 Chemicals and Materials, BY Application (USD Billion)
  1. 4.4.1 Chronic Kidney Disease
  2. 4.4.2 Nutritional Deficiency
  3. 4.4.3 Neurological & Psychological Disorders
  4. 4.4.4 Metabolic Disorders
  5. 4.4.5 Pain Management
  6. 4.4.6 Gastrointestinal Disorders
  7. 4.4.7 Orphan diseases
  8. 4.4.8 Others
5. 4.5 Chemicals and Materials, BY Distribution Channel (USD Billion)
  1. 4.5.1 E-commerce
  2. 4.5.2 Hospital Pharmacies
  3. 4.5.3 Retail Pharmacies
  4. 4.5.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Nestle (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Danone (FR)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Mead Johnson Nutrition (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Baxter International (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Fresenius Kabi (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hormel Foods (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Reckitt Benckiser (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Perrigo (IE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY NUTRITIONAL INGREDIENTS
3. 6.3 US MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
4. 6.4 US MARKET ANALYSIS BY FORM
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
13. 6.13 CHEMICALS AND MATERIALS, BY NUTRITIONAL INGREDIENTS, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY NUTRITIONAL INGREDIENTS, 2024 TO 2035 (USD Billion)
15. 6.15 CHEMICALS AND MATERIALS, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Billion)
17. 6.17 CHEMICALS AND MATERIALS, BY FORM, 2024 (% SHARE)
18. 6.18 CHEMICALS AND MATERIALS, BY FORM, 2024 TO 2035 (USD Billion)
19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
20. 6.20 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
21. 6.21 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. 6.22 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY NUTRITIONAL INGREDIENTS, 2025-2035 (USD Billion)
  2. 7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY FORM, 2025-2035 (USD Billion)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
  5. 7.2.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Nutritional Ingredients (USD Billion, 2025-2035)

Vitamins and Minerals
Proteins
Omega-3
Isoflavones
Phytosterols
Others

Chemicals and Materials By Route of Administration (USD Billion, 2025-2035)

Oral
Enteral

Chemicals and Materials By Form (USD Billion, 2025-2035)

Pills
Powder
Others

Chemicals and Materials By Application (USD Billion, 2025-2035)

Chronic Kidney Disease
Nutritional Deficiency
Neurological & Psychological Disorders
Metabolic Disorders
Pain Management
Gastrointestinal Disorders
Orphan diseases
Others

Chemicals and Materials By Distribution Channel (USD Billion, 2025-2035)

E-commerce
Hospital Pharmacies
Retail Pharmacies
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”